Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Peripheral perfusion fails septic shock test, but optimism remains
MDedge Emergency Medicine
Trump targets abortion by denying family planning funds
MDedge Emergency Medicine
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Emergency Medicine
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Emergency Medicine
Infective endocarditis isn’t what it used to be
MDedge Emergency Medicine
Esketamine gets the green light for depression
MDedge Emergency Medicine
Ready for universal hepatitis C testing?
MDedge Emergency Medicine
Autism risk with in utero infections
MDedge Emergency Medicine
Aspirin and lower risk of COPD flare-up
MDedge Emergency Medicine
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Emergency Medicine